| [1] |
Filipowicz W. Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? [J]. Nat Rev Genet, 2008, 9(2): 102-114.
|
| [2] |
Fang Z, Du R, Edwards A, et al. The sequence structures of human microRNA molecules and their implications [J]. PLoS One, 2013, 8(1): e54215.
|
| [3] |
Baek D, Villén J, Shin C, et al. The impact of microRNAs on protein output [J]. Nature, 2008, 455(7209):64-71.
|
| [4] |
Bartel DP. MicroRNAs: target recognition and regulatory functions [J]. Cell, 2009, 136(2): 215-233.
|
| [5] |
Li L, Luo J, Wang B, et al. MicroRNA-124 targets flotillin-1 to regulate proliferation and migration in breast cancer [J]. Mol Cancer, 2013, 12:163.
|
| [6] |
Zhu ED, Li N, Li BS, et al. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1 [J]. PLoS One, 2014, 9(8):e106049.
|
| [7] |
Liu T, Tang H, Lang Y, et al. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin [J]. Cancer Lett, 2009, 273(2):233-242.
|
| [8] |
Piva R, Spandidos DA, Gambari R. From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment[J]. Int J Oncol, 2013, 43(4): 985-994.
|
| [9] |
韩晓翠，左晓丽，李敏，等. 微RNA 221/222在乳腺癌中的研究进展[J/CD]. 中华乳腺病杂志(电子版), 2017，11(6): 369-371.
|
| [10] |
Kim SY, Kim AY, Lee HW, et al. miRNA-27a is a negative regulator of adipocyte differentiation via suppressing PPAR gamma expression [J]. Biochem Biophys Res Commun, 2010, 392(3): 323-328.
|
| [11] |
Lin Q, Gao Z, Alarcon RM, et al. A role of miR-27 in the regulation of adipogenesis [J]. FEBS J, 2009, 276(8): 2348-2358.
|
| [12] |
Hua K, Chen Y, Chen CF, et al. MicroRNA-23a/27a/24-2 cluster promotes gastric cancer cell proliferation synergistically [J]. Oncol Lett, 2018, 16(2): 2319-2325.
|
| [13] |
Feng J, Iwama A, Satake M, et al. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1[J]. Br J Haematol, 2009, 145(3):412-423.
|
| [14] |
Mertens-Talcott SU, Chintharlapalli S, Li X, et al. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells [J]. Cancer Res, 2007, 67(22): 11 001-11 011.
|
| [15] |
Wang X, Tang S, Le SY, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth[J]. PLoS One, 2008, 3(7): e2557.
|
| [16] |
Zhou S, Huang Q, Zheng S, et al. miRNA-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis [J]. Tumour Biol, 2016, 37(5): 6837-6845.
|
| [17] |
Ye P, Fang C, Zeng H, et al. Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods [J]. Oncol Lett, 2018, 15(3): 3532-3539.
|
| [18] |
Tang W, Zhu J, Su S, et al. MiR-27 as a prognostic marker for breast cancer progression and patient survival [J]. PLoS One, 2012, 7(12): e51702.
|
| [19] |
Kong LY, Xue M, Zhang QC, et al. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway[J]. Oncotarget, 2017, 8(9): 15 507-15 519.
|
| [20] |
Jurkovicova D, Magyerkova M, Sestakova Z, et al. Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer [J]. Neoplasma, 2016, 63(6): 941.
|
| [21] |
Gasparini P, Cascione L, Fassan M, et al. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers[J]. Oncotarget, 2014, 5(5): 1174-1184.
|
| [22] |
Li M, Han Y, Zhou H, et al. Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/β-catenin pathway [J]. Cell Death Dis, 2018, 9(2): 91.
|
| [23] |
Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters [J]. Nat Rev Cancer, 2002, 2(1): 48-58.
|
| [24] |
Toscano-Garibay JD, Aquino-Jarquin G. Regulation exerted by miRNAs in the promoter and UTR sequences: MDR1/P-gp expression as a particular case [J]. DNA Cell Biol, 2012, 31(8): 1358-1364.
|
| [25] |
Chen Z, Ma T, Huang C, et al. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells [J]. Cell Signal, 2013, 25(12): 2693-2701.
|
| [26] |
Feng DD, Zhang H, Zhang P, et al. Down-regulated miR-331-5p and miRNA-27a are associated with chemotherapy resistance and relapse in leukaemia [J]. J Cell Mol Med, 2011, 15(10): 2164-2175.
|
| [27] |
Zhao X, Yang L, Hu J. Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells [J]. J Exp Clin Cancer Res, 2011, 30: 55.
|
| [28] |
Li Z, Hu S, Wang J, et al. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells [J]. Gynecol Oncol, 2010, 119(1): 125-130.
|
| [29] |
Wu J, Sun Z, Sun H, et al. MicroRNA27a promotes tumorigenesis via targeting AKT in triple negative breast cancer[J]. Mol Med Rep, 2018, 17(1): 562-570.
|
| [30] |
Guttilla IK, White BA. Coordinate regulation of FOXO1 by miRNA-27a, miR-96, and miR-182 in breast cancer cells [J]. J Biol Chem, 2009, 284(35): 23 204-23 216.
|
| [31] |
Li X, Mertens-Talcott SU, Zhang S, et al. MicroRNA-27a indirectly regulates estrogen receptor alpha expression and hormone responsiveness in MCF-7 breast cancer cells[J]. Endocrinology, 2010, 151(6):2462-2473.
|
| [32] |
Mertens-Talcott SU, Noratto GD, Li X, et al. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a：ZBTB10 [J]. Mol Carcinog, 2013, 52(8): 591-602.
|
| [33] |
Abdelrahim M, Smith R 3rd, Burghardt R, et al. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells [J]. Cancer Res, 2004, 64(18): 6740-6749.
|
| [34] |
Qi J, Yu Y, Akilli Öztürk Ö，et al. New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals [J]. Gut, 2015, 65(10): 1690-1701.
|
| [35] |
Zhao W, Zhang X, Liu J, et al. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7 [J]. Oncol Rep, 2016, 36(6): 3691-3699.
|
| [36] |
Zhao W, Zhang X, Zhou Z, et al. Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression [J]. Mol Med Rep, 2018, 17(4): 5202-5212.
|